ImmuSmol

ImmuSmol is specialized in developing antibodies directed against small molecules. Supported by public institutions including BPI, Conseil Régional Nouvelle Aquitaine, as well as by its Co-founder Associate – SCHIEVER, Immusmol is established in Bordeaux, France.
The ImmuSmol team is made up of around twenty talents with different backgrounds and application fields, bringing their expertise and experience to the company. ImmuSmol aims to become a natural choice for small molecule antibodies development, collaborating with a worldwide network of scientists.
ImmuSmol’s focus: validated tools for detecting small molecules
ImmuSmol stands for antibodies against small molecules. While traditional antibodies only recognize large molecules such as proteins, ImmuSmol designs and develops antibodies capable of targeting low molecular weight entities, below 900 Daltons, that can be used for conventional staining applications as well as in the scope of novel immunoassays development
Their products are fully compatible with existing antibody-based technologies, small molecule antibodies are opening a whole new set of possibilities in research diagnostic and therapeutic applications.

The prices are on request! Contact Us by e-mail info@sobekbio.com

Recombinant anti-2019-nCoV NP ScFv (4A6) DA028

The add to cart button will appear once you select the values above

Specifications

size	50ug\|500ug\|1mg

Alias:

Classification:

Immuno-Diagnostics Reagents

Product information:

Recombinant anti-2019-nCoV NP ScFv is produced by our E.coli expression system with a 6His, Flag tag at the C-terminus.

Species:

Isotype:

Single-chain variable fragment Clone#4A6

Conjugate tag:

Source:

E.coli

Formula:

Supplied as a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Molecular weight:

Purity:

Animal ingredients:

None

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com